Drug Pricing ‘Solutions’ Coming In Future Phase Of US Healthcare Reform, Sec. Price Says

The Trump Administration expects that prescription drug affordability will be addressed in future “phases” of the Affordable Care Act (ACA) repeal and replace process, HHS Secretary Tom Price said during the daily White House press briefing March 7.

Drug pricing is not addressed in the House legislation unveiled the evening before by the House Energy and Commerce and Ways and Means Committees. Those bills, which address issues falling under the respective jurisdiction of the two committees, are focused on unwinding some of the tax and financing provisions of the ACA